Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Other Non Operating Income (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Other Non Operating Income for 14 consecutive years, with $930.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 99.91% year-over-year to $930.0, compared with a TTM value of -$49974.0 through Sep 2025, up 98.79%, and an annual FY2024 reading of $97188.0, down 42.72% over the prior year.
  • Other Non Operating Income was $930.0 for Q3 2025 at BioRestorative Therapies, down from $636525.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.0 million in Q3 2024 and bottomed at -$3.3 million in Q4 2023.
  • Average Other Non Operating Income over 4 years is -$326628.1, with a median of $17440.5 recorded in 2023.
  • Peak annual rise in Other Non Operating Income hit 2952.82% in 2024, while the deepest fall reached 4462.03% in 2024.
  • Year by year, Other Non Operating Income stood at $124372.0 in 2022, then crashed by 2758.87% to -$3.3 million in 2023, then surged by 98.39% to -$53310.0 in 2024, then skyrocketed by 101.74% to $930.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BRTX at $930.0 in Q3 2025, $636525.0 in Q2 2025, and -$634119.0 in Q1 2025.